Big Pharma Archives - Ashvinmedicara

Big Pharma Profits by Keeping Us Sick: The Truth Behind Chronic Treatments

Brian RogersJune 13, 20240184 views

Pharmaceutical companies operate on business models that emphasize continuous revenue streams, particularly through the treatment of chronic conditions like diabetes, hypertension, and high cholesterol. This approach contrasts sharply with the one-time profit from a cure. While treatments for diseases such as HIV and cancer generate ongoing revenue, the development and prioritization of cures face numerous economic and regulatory hurdles. Critics argue that Big Pharma’s focus on profit leads to the suppression of potential cures, and regulatory bodies and market control entities, like LegitScript, often act to maintain this status quo. This article examines the inherent economic incentives in the pharmaceutical industry that prioritize treatments over cures, the suppression of natural remedies, and the broader implications for global health.

How US Prescription Policies Favor Profits Over Patient Care

Brian RogersJune 6, 20240173 views

In the U.S., the process of obtaining medications involves doctor visits, high costs, and limited accessibility, leading to lower customer satisfaction. Other countries with broad over-the-counter (OTC) availability enjoy higher customer satisfaction and easier access to medications. This article compares customer satisfaction, health outcomes, and economic impact between the U.S. and other countries, highlighting the need for the U.S. to consider a hybrid model that balances regulation with accessibility, and explores the potential benefits of allowing verified online pharmacies from India to ship medications to the U.S.

Economic and Racial Inequities in U.S. Healthcare Policy

Brian RogersJune 6, 20240187 views

The U.S. healthcare crisis is deeply linked to socioeconomic and racial inequalities, driven by policies set by affluent white males that often neglect the needs of African Americans, Latinos, and other people of color. This article examines the disparities within the system, the higher rates of genetic diseases among these populations, and the economic barriers to healthcare they face. It advocates for reforms to ensure equitable access to affordable healthcare for all.

Safety or Profit? The Prescription Drug Classification Dilemma

Brian RogersJune 6, 20240204 views

The classification of prescription medications varies significantly between countries, reflecting different healthcare systems and regulatory environments. In the U.S., the FDA classifies many drugs as prescription-only based on safety and abuse potential. Conversely, countries like India and Thailand allow over-the-counter access to many of these medications. This article explores the reasons behind these differences and examines whether U.S. regulations are driven by safety concerns or commercial interests, and how reclassification could potentially reduce healthcare costs and improve access.

The False Promise of U.S. Healthcare Reform: Why Costs Keep Rising

Brian RogersJune 5, 20240136 views

Despite government-led initiatives aimed at reducing healthcare costs, such as the Affordable Care Act enhancements and drug price negotiations, these measures have largely failed to provide significant savings for the average American. This article explores the reasons behind the ineffectiveness of these programs, comparing them to the systems in other countries, and examines whether they serve more to maintain the status quo than to deliver meaningful reform.

Future at a Crossroads: The Escalating Cost of Living and Healthcare in America

Brian RogersJune 4, 20240140 views

As the trajectory of America’s economic and healthcare landscape points towards rising healthcare costs, corporate monopolization of essential services, and stagnant wage growth, the future appears daunting. A family of four may soon need to earn $200,000 annually by 2034 just to manage healthcare expenses. This article explores the systemic issues leading to these trends and their impact on daily living, emphasizing the need for significant policy changes to prevent an unsustainable future dominated by financial burdens and health disparities. The influence of big pharmaceutical companies, the monopolization of food production, and the socio-economic challenges faced by lower-income communities highlight the urgent need for reforms in healthcare and economic policies.

Beyond the Patents: The Monopoly Practices of Big Pharma and What American Consumers Aren’t Told

Brian RogersJune 3, 20240205 views

The high cost of prescription drugs in the U.S. is driven by Big Pharma’s patent practices and strategic blocking of affordable generic medications, especially from India. This article reveals how evergreening tactics, intense lobbying, and restrictive FDA regulations keep drug prices artificially high and prevent the entry of cheaper alternatives. These monopoly practices significantly impact consumers, leading to high healthcare costs and limited access to essential medications. Organizations like Ashvin Medicara play a crucial role in advocating for the importation of safe and affordable generics, challenging the power of Big Pharma and supporting policy changes for better healthcare access.

Healthcare Betrayal: Are Americans Dying Due to the High Costs Imposed by Big Pharma and the Government?

Brian RogersJune 3, 20240153 views

The relationship between pharmaceutical companies, the government, and the healthcare system raises significant legal and ethical questions. This article explores whether actions by these entities to block or limit access to affordable generic medications could be considered criminal negligence, manslaughter, or even murder. By examining legal frameworks and theoretical applications, the discussion delves into how these practices may infringe on public health, highlighting the ethical implications and the need for regulatory and corporate accountability.

The Silent Conspiracy: How Regulators and Corporations Control Your Health

Brian RogersJune 3, 20240158 views

The regulatory landscape involving entities like the FDA, LegitScript, Meta, and Google is often seen as a guardian of public health. However, a closer look reveals that, much like underground steroid forums, these organizations control information and access to healthcare products for financial gain. This article explores the parallels between these mainstream and underground entities, highlighting how they prioritize profits over genuine healthcare needs. The discussion covers the manipulation of health information, censorship, and the economic interests driving these practices. It also advocates for regulatory reforms and supports organizations like Ashvin Medicara, which promote transparency and access to affordable medications.

Healthcare and Control: The Corporate Takeover of America

Brian RogersJune 2, 20240141 views

In the shadows of America’s sprawling metropolises and through the silent bytes of digital communication, a more sinister vision of the future is being forged—one where the illusion of freedom masks an unsettling reality. This article exposes how an elite cabal of corporations and their billionaire figureheads are orchestrating a future where they hold unchallenged dominion over every facet of American life, from our healthcare and food supply to our economic stability and personal liberties. These corporate overlords seek to monopolize health services, turning basic healthcare into a luxury item only the wealthy can afford, while digital surveillance grants them unprecedented control over personal data. Political leaders, seduced by corporate donations, become mere puppets ensuring laws protect these monopolies. This orchestrated control aims to create a dependent society, where true freedom becomes a relic of the past. Recognizing and challenging these forces is crucial to reclaiming the essence of American life and liberty.